Skip to main content

Market Overview

Mike Khouw Highlights Unusual Options Activity In Biogen

Mike Khouw Highlights Unusual Options Activity In Biogen

On CNBC's "Options Action," Mike Khouw spoke about unusually high options activity in Biogen Inc (NASDAQ: BIIB). He noticed on both Tuesday and Wednesday that puts outpaced calls by about 2 to 1.

See Also: Target Option Traders Turn Bearish Following Big Holiday Shopping Weekend

The market is implying a move of 7% in either direction this week when the company is going to release the latest clinical trial results. During the session on Wednesday, Khouw noticed a big activity in the December weekly, $275 puts, which traded for $4.26. The trade breaks even at $270.74 or 5.61% below the current stock price.

Editor's note: The company's clinical trial results are expected Thursday morning and had not yet been published at time of writing.


Related Articles (BIIB)

View Comments and Join the Discussion!

Posted-In: CNBC Mike Khouw Options ActionOptions Markets Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at